X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - ZACKS.COM - All Stories - 27/Feb 13:20

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Tops Revenue Estimates

Aclaris (ACRS) delivered earnings and revenue surprises of 68.75% and 313.05%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

Verve Therapeutics (VERV) Reports Q4 Loss, Tops Revenue Estimates

zacks.com - 27/Feb 13:25

Verve Therapeutics (VERV) delivered earnings and revenue surprises of 19.44% and 90.39%, respectively, for the quarter ended December 2024. Do the...

Sorry! Image not available at this time

Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates

zacks.com - 27/Feb 13:45

Intellia Therapeutics (NTLA) delivered earnings and revenue surprises of 6.06% and 45.95%, respectively, for the quarter ended December 2024. Do the...

Sorry! Image not available at this time

Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates

zacks.com - 05/Mar 22:10

Fate Therapeutics (FATE) delivered earnings and revenue surprises of 29.55% and 46.46%, respectively, for the quarter ended December 2024. Do the...

Sorry! Image not available at this time

C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Lags Revenue Estimates

zacks.com - 27/Feb 13:15

C4 Therapeutics (CCCC) delivered earnings and revenue surprises of -11.36% and 39.45%, respectively, for the quarter ended December 2024. Do the...

Sorry! Image not available at this time

Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates

zacks.com - 27/Feb 13:15

Kymera Therapeutics (KYMR) delivered earnings and revenue surprises of -15.79% and 43.50%, respectively, for the quarter ended December 2024. Do the...

Sorry! Image not available at this time

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates

zacks.com - 27/Feb 13:15

Tango Therapeutics (TNGX) delivered earnings and revenue surprises of -9.38% and 47.46%, respectively, for the quarter ended December 2024. Do the...

Sorry! Image not available at this time

Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Lags Revenue Estimates

zacks.com - 27/Feb 13:25

Viridian Therapeutics (VRDN) delivered earnings and revenue surprises of 22.86% and 17.24%, respectively, for the quarter ended December 2024. Do the...

Sorry! Image not available at this time

Keros Therapeutics, Inc. (KROS) Reports Q4 Loss, Misses Revenue Estimates

zacks.com - 26/Feb 22:10

Keros Therapeutics (KROS) delivered earnings and revenue surprises of -22.58% and 97.11%, respectively, for the quarter ended December 2024. Do the...

Sorry! Image not available at this time

Aquestive Therapeutics (AQST) Reports Q4 Loss, Lags Revenue Estimates

zacks.com - 05/Mar 22:10

Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -35.71% and 12.11%, respectively, for the quarter ended December 2024. Do...

Sorry! Image not available at this time

Pinnacle West (PNW) Reports Q4 Loss, Tops Revenue Estimates

zacks.com - 25/Feb 14:40

Pinnacle West (PNW) delivered earnings and revenue surprises of 60% and 3.61%, respectively, for the quarter ended December 2024. Do the numbers hold...

Les derniers communiqués